Summary
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
According to APO Research, The global Animal Stem Cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Animal Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Animal Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Animal Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Animal Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Animal Stem Cell Therapy include Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, VetCell Therapeutics, Celavet Inc., Magellan Stem Cells, Kintaro Cells Power and Animal Stem Care, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Animal Stem Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Animal Stem Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Stem Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal Stem Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Animal Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Animal Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Animal Stem Cell Therapy segment by Company
Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Animal Stem Cell Therapy segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others Animals
Animal Stem Cell Therapy segment by Application
Veterinary Hospitals
Research Organizations
Animal Stem Cell Therapy segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Animal Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Animal Stem Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Stem Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Animal Stem Cell Therapy Market by Type
1.2.1 Global Animal Stem Cell Therapy Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Dogs Stem Cell Therapy
1.2.3 Horses Stem Cell Therapy
1.2.4 Others Animals
1.3 Animal Stem Cell Therapy Market by Application
1.3.1 Global Animal Stem Cell Therapy Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Research Organizations
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Animal Stem Cell Therapy Market Dynamics
2.1 Animal Stem Cell Therapy Industry Trends
2.2 Animal Stem Cell Therapy Industry Drivers
2.3 Animal Stem Cell Therapy Industry Opportunities and Challenges
2.4 Animal Stem Cell Therapy Industry Restraints
3 Global Growth Perspective
3.1 Global Animal Stem Cell Therapy Market Perspective (2019-2030)
3.2 Global Animal Stem Cell Therapy Growth Trends by Region
3.2.1 Global Animal Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Animal Stem Cell Therapy Market Size by Region (2019-2024)
3.2.3 Global Animal Stem Cell Therapy Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Animal Stem Cell Therapy Revenue by Players
4.1.1 Global Animal Stem Cell Therapy Revenue by Players (2019-2024)
4.1.2 Global Animal Stem Cell Therapy Revenue Market Share by Players (2019-2024)
4.1.3 Global Animal Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Animal Stem Cell Therapy Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Animal Stem Cell Therapy Key Players Headquarters & Area Served
4.4 Global Animal Stem Cell Therapy Players, Product Type & Application
4.5 Global Animal Stem Cell Therapy Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Animal Stem Cell Therapy Market CR5 and HHI
4.6.2 Global Top 5 and 10 Animal Stem Cell Therapy Players Market Share by Revenue in 2023
4.6.3 2023 Animal Stem Cell Therapy Tier 1, Tier 2, and Tier 3
5 Animal Stem Cell Therapy Market Size by Type
5.1 Global Animal Stem Cell Therapy Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Animal Stem Cell Therapy Revenue by Type (2019-2030)
5.3 Global Animal Stem Cell Therapy Revenue Market Share by Type (2019-2030)
6 Animal Stem Cell Therapy Market Size by Application
6.1 Global Animal Stem Cell Therapy Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Animal Stem Cell Therapy Revenue by Application (2019-2030)
6.3 Global Animal Stem Cell Therapy Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Medivet Biologics LLC
7.1.1 Medivet Biologics LLC Comapny Information
7.1.2 Medivet Biologics LLC Business Overview
7.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Product Portfolio
7.1.5 Medivet Biologics LLC Recent Developments
7.2 VETSTEM BIOPHARMA
7.2.1 VETSTEM BIOPHARMA Comapny Information
7.2.2 VETSTEM BIOPHARMA Business Overview
7.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Product Portfolio
7.2.5 VETSTEM BIOPHARMA Recent Developments
7.3 J-ARM
7.3.1 J-ARM Comapny Information
7.3.2 J-ARM Business Overview
7.3.3 J-ARM Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.3.4 J-ARM Animal Stem Cell Therapy Product Portfolio
7.3.5 J-ARM Recent Developments
7.4 U.S. Stem Cell, Inc
7.4.1 U.S. Stem Cell, Inc Comapny Information
7.4.2 U.S. Stem Cell, Inc Business Overview
7.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Product Portfolio
7.4.5 U.S. Stem Cell, Inc Recent Developments
7.5 VetCell Therapeutics
7.5.1 VetCell Therapeutics Comapny Information
7.5.2 VetCell Therapeutics Business Overview
7.5.3 VetCell Therapeutics Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.5.4 VetCell Therapeutics Animal Stem Cell Therapy Product Portfolio
7.5.5 VetCell Therapeutics Recent Developments
7.6 Celavet Inc.
7.6.1 Celavet Inc. Comapny Information
7.6.2 Celavet Inc. Business Overview
7.6.3 Celavet Inc. Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.6.4 Celavet Inc. Animal Stem Cell Therapy Product Portfolio
7.6.5 Celavet Inc. Recent Developments
7.7 Magellan Stem Cells
7.7.1 Magellan Stem Cells Comapny Information
7.7.2 Magellan Stem Cells Business Overview
7.7.3 Magellan Stem Cells Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.7.4 Magellan Stem Cells Animal Stem Cell Therapy Product Portfolio
7.7.5 Magellan Stem Cells Recent Developments
7.8 Kintaro Cells Power
7.8.1 Kintaro Cells Power Comapny Information
7.8.2 Kintaro Cells Power Business Overview
7.8.3 Kintaro Cells Power Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.8.4 Kintaro Cells Power Animal Stem Cell Therapy Product Portfolio
7.8.5 Kintaro Cells Power Recent Developments
7.9 Animal Stem Care
7.9.1 Animal Stem Care Comapny Information
7.9.2 Animal Stem Care Business Overview
7.9.3 Animal Stem Care Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.9.4 Animal Stem Care Animal Stem Cell Therapy Product Portfolio
7.9.5 Animal Stem Care Recent Developments
7.10 Animal Cell Therapies
7.10.1 Animal Cell Therapies Comapny Information
7.10.2 Animal Cell Therapies Business Overview
7.10.3 Animal Cell Therapies Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.10.4 Animal Cell Therapies Animal Stem Cell Therapy Product Portfolio
7.10.5 Animal Cell Therapies Recent Developments
7.11 Cell Therapy Sciences
7.11.1 Cell Therapy Sciences Comapny Information
7.11.2 Cell Therapy Sciences Business Overview
7.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Product Portfolio
7.11.5 Cell Therapy Sciences Recent Developments
7.12 Animacel
7.12.1 Animacel Comapny Information
7.12.2 Animacel Business Overview
7.12.3 Animacel Animal Stem Cell Therapy Revenue and Gross Margin (2019-2024)
7.12.4 Animacel Animal Stem Cell Therapy Product Portfolio
7.12.5 Animacel Recent Developments
8 North America
8.1 North America Animal Stem Cell Therapy Revenue (2019-2030)
8.2 North America Animal Stem Cell Therapy Revenue by Type (2019-2030)
8.2.1 North America Animal Stem Cell Therapy Revenue by Type (2019-2024)
8.2.2 North America Animal Stem Cell Therapy Revenue by Type (2025-2030)
8.3 North America Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
8.4 North America Animal Stem Cell Therapy Revenue by Application (2019-2030)
8.4.1 North America Animal Stem Cell Therapy Revenue by Application (2019-2024)
8.4.2 North America Animal Stem Cell Therapy Revenue by Application (2025-2030)
8.5 North America Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
8.6 North America Animal Stem Cell Therapy Revenue by Country
8.6.1 North America Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Animal Stem Cell Therapy Revenue by Country (2019-2024)
8.6.3 North America Animal Stem Cell Therapy Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Animal Stem Cell Therapy Revenue (2019-2030)
9.2 Europe Animal Stem Cell Therapy Revenue by Type (2019-2030)
9.2.1 Europe Animal Stem Cell Therapy Revenue by Type (2019-2024)
9.2.2 Europe Animal Stem Cell Therapy Revenue by Type (2025-2030)
9.3 Europe Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
9.4 Europe Animal Stem Cell Therapy Revenue by Application (2019-2030)
9.4.1 Europe Animal Stem Cell Therapy Revenue by Application (2019-2024)
9.4.2 Europe Animal Stem Cell Therapy Revenue by Application (2025-2030)
9.5 Europe Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
9.6 Europe Animal Stem Cell Therapy Revenue by Country
9.6.1 Europe Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Animal Stem Cell Therapy Revenue by Country (2019-2024)
9.6.3 Europe Animal Stem Cell Therapy Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Animal Stem Cell Therapy Revenue (2019-2030)
10.2 China Animal Stem Cell Therapy Revenue by Type (2019-2030)
10.2.1 China Animal Stem Cell Therapy Revenue by Type (2019-2024)
10.2.2 China Animal Stem Cell Therapy Revenue by Type (2025-2030)
10.3 China Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
10.4 China Animal Stem Cell Therapy Revenue by Application (2019-2030)
10.4.1 China Animal Stem Cell Therapy Revenue by Application (2019-2024)
10.4.2 China Animal Stem Cell Therapy Revenue by Application (2025-2030)
10.5 China Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Animal Stem Cell Therapy Revenue (2019-2030)
11.2 Asia Animal Stem Cell Therapy Revenue by Type (2019-2030)
11.2.1 Asia Animal Stem Cell Therapy Revenue by Type (2019-2024)
11.2.2 Asia Animal Stem Cell Therapy Revenue by Type (2025-2030)
11.3 Asia Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
11.4 Asia Animal Stem Cell Therapy Revenue by Application (2019-2030)
11.4.1 Asia Animal Stem Cell Therapy Revenue by Application (2019-2024)
11.4.2 Asia Animal Stem Cell Therapy Revenue by Application (2025-2030)
11.5 Asia Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
11.6 Asia Animal Stem Cell Therapy Revenue by Country
11.6.1 Asia Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Animal Stem Cell Therapy Revenue by Country (2019-2024)
11.6.3 Asia Animal Stem Cell Therapy Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Animal Stem Cell Therapy Revenue (2019-2030)
12.2 MEALA Animal Stem Cell Therapy Revenue by Type (2019-2030)
12.2.1 MEALA Animal Stem Cell Therapy Revenue by Type (2019-2024)
12.2.2 MEALA Animal Stem Cell Therapy Revenue by Type (2025-2030)
12.3 MEALA Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
12.4 MEALA Animal Stem Cell Therapy Revenue by Application (2019-2030)
12.4.1 MEALA Animal Stem Cell Therapy Revenue by Application (2019-2024)
12.4.2 MEALA Animal Stem Cell Therapy Revenue by Application (2025-2030)
12.5 MEALA Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
12.6 MEALA Animal Stem Cell Therapy Revenue by Country
12.6.1 MEALA Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Animal Stem Cell Therapy Revenue by Country (2019-2024)
12.6.3 MEALA Animal Stem Cell Therapy Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Animal Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Dogs Stem Cell Therapy Major Manufacturers
Table 2. Horses Stem Cell Therapy Major Manufacturers
Table 3. Others Animals Major Manufacturers
Table 4. Global Animal Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Veterinary Hospitals Major Manufacturers
Table 6. Research Organizations Major Manufacturers
Table 7. Animal Stem Cell Therapy Industry Trends
Table 8. Animal Stem Cell Therapy Industry Drivers
Table 9. Animal Stem Cell Therapy Industry Opportunities and Challenges
Table 10. Animal Stem Cell Therapy Industry Restraints
Table 11. Global Animal Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Animal Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Animal Stem Cell Therapy Market Share by Region (2019-2024)
Table 14. Global Animal Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Animal Stem Cell Therapy Market Share by Region (2025-2030)
Table 16. Global Animal Stem Cell Therapy Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Animal Stem Cell Therapy Revenue Market Share by Players (2019-2024)
Table 18. Global Animal Stem Cell Therapy Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Animal Stem Cell Therapy Key Players Headquarters & Area Served
Table 20. Global Animal Stem Cell Therapy Players, Product Type & Application
Table 21. Global Animal Stem Cell Therapy Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Animal Stem Cell Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Animal Stem Cell Therapy Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Animal Stem Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Animal Stem Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Animal Stem Cell Therapy Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Animal Stem Cell Therapy Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Animal Stem Cell Therapy Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Animal Stem Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Animal Stem Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Animal Stem Cell Therapy Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Animal Stem Cell Therapy Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Medivet Biologics LLC Company Information
Table 35. Medivet Biologics LLC Business Overview
Table 36. Medivet Biologics LLC Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Medivet Biologics LLC Animal Stem Cell Therapy Product Portfolio
Table 38. Medivet Biologics LLC Recent Development
Table 39. VETSTEM BIOPHARMA Company Information
Table 40. VETSTEM BIOPHARMA Business Overview
Table 41. VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. VETSTEM BIOPHARMA Animal Stem Cell Therapy Product Portfolio
Table 43. VETSTEM BIOPHARMA Recent Development
Table 44. J-ARM Company Information
Table 45. J-ARM Business Overview
Table 46. J-ARM Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. J-ARM Animal Stem Cell Therapy Product Portfolio
Table 48. J-ARM Recent Development
Table 49. U.S. Stem Cell, Inc Company Information
Table 50. U.S. Stem Cell, Inc Business Overview
Table 51. U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. U.S. Stem Cell, Inc Animal Stem Cell Therapy Product Portfolio
Table 53. U.S. Stem Cell, Inc Recent Development
Table 54. VetCell Therapeutics Company Information
Table 55. VetCell Therapeutics Business Overview
Table 56. VetCell Therapeutics Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. VetCell Therapeutics Animal Stem Cell Therapy Product Portfolio
Table 58. VetCell Therapeutics Recent Development
Table 59. Celavet Inc. Company Information
Table 60. Celavet Inc. Business Overview
Table 61. Celavet Inc. Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Celavet Inc. Animal Stem Cell Therapy Product Portfolio
Table 63. Celavet Inc. Recent Development
Table 64. Magellan Stem Cells Company Information
Table 65. Magellan Stem Cells Business Overview
Table 66. Magellan Stem Cells Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Magellan Stem Cells Animal Stem Cell Therapy Product Portfolio
Table 68. Magellan Stem Cells Recent Development
Table 69. Kintaro Cells Power Company Information
Table 70. Kintaro Cells Power Business Overview
Table 71. Kintaro Cells Power Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Kintaro Cells Power Animal Stem Cell Therapy Product Portfolio
Table 73. Kintaro Cells Power Recent Development
Table 74. Animal Stem Care Company Information
Table 75. Animal Stem Care Business Overview
Table 76. Animal Stem Care Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Animal Stem Care Animal Stem Cell Therapy Product Portfolio
Table 78. Animal Stem Care Recent Development
Table 79. Animal Cell Therapies Company Information
Table 80. Animal Cell Therapies Business Overview
Table 81. Animal Cell Therapies Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Animal Cell Therapies Animal Stem Cell Therapy Product Portfolio
Table 83. Animal Cell Therapies Recent Development
Table 84. Cell Therapy Sciences Company Information
Table 85. Cell Therapy Sciences Business Overview
Table 86. Cell Therapy Sciences Animal Stem Cell Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Cell Therapy Sciences Animal Stem Cell Therapy Product Portfolio
Table 88. Cell Therapy Sciences Recent Development
Table 89. Animacel Company Information
Table 90. Animacel Business Overview
Table 91. Animacel Animal Stem Cell Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Animacel Animal Stem Cell Therapy Product Portfolio
Table 93. Animacel Recent Development
Table 94. North America Animal Stem Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 95. North America Animal Stem Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 96. North America Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 97. North America Animal Stem Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 98. North America Animal Stem Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 99. Europe Animal Stem Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 100. Europe Animal Stem Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 101. Europe Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 102. Europe Animal Stem Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 103. Europe Animal Stem Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 104. China Animal Stem Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 105. China Animal Stem Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 106. Asia Animal Stem Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 107. Asia Animal Stem Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 108. Asia Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 109. Asia Animal Stem Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 110. Asia Animal Stem Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 111. MEALA Animal Stem Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 112. MEALA Animal Stem Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 113. MEALA Animal Stem Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. MEALA Animal Stem Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 115. MEALA Animal Stem Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 116. Research Programs/Design for This Report
Table 117. Authors List of This Report
Table 118. Secondary Sources
Table 119. Primary Sources
List of Figures
Figure 1. Animal Stem Cell Therapy Product Picture
Figure 2. Global Animal Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Animal Stem Cell Therapy Market Size Share 2019 VS 2023 VS 2030
Figure 4. Dogs Stem Cell Therapy Picture
Figure 5. Horses Stem Cell Therapy Picture
Figure 6. Others Animals Picture
Figure 7. Global Animal Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Animal Stem Cell Therapy Market Size Share 2019 VS 2023 VS 2030
Figure 9. Veterinary Hospitals Picture
Figure 10. Research Organizations Picture
Figure 11. Global Animal Stem Cell Therapy Market Size (US$ Million) & (2019-2030)
Figure 12. Global Animal Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Animal Stem Cell Therapy Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Animal Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Animal Stem Cell Therapy Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Animal Stem Cell Therapy Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Animal Stem Cell Therapy Revenue Market Share by Type (2019-2030)
Figure 19. Global Animal Stem Cell Therapy Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Animal Stem Cell Therapy Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Animal Stem Cell Therapy Revenue Market Share by Application (2019-2030)
Figure 22. North America Animal Stem Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Animal Stem Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
Figure 25. North America Animal Stem Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
Figure 27. North America Animal Stem Cell Therapy Revenue Share by Country (2019-2030)
Figure 28. United States Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Animal Stem Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Animal Stem Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
Figure 33. Europe Animal Stem Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
Figure 35. Europe Animal Stem Cell Therapy Revenue Share by Country (2019-2030)
Figure 36. Germany Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Animal Stem Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Animal Stem Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
Figure 45. China Animal Stem Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
Figure 47. Asia Animal Stem Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Animal Stem Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
Figure 50. Asia Animal Stem Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
Figure 52. Asia Animal Stem Cell Therapy Revenue Share by Country (2019-2030)
Figure 53. Japan Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Animal Stem Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Animal Stem Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Animal Stem Cell Therapy Revenue Share by Type (2019-2030)
Figure 62. MEALA Animal Stem Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Animal Stem Cell Therapy Revenue Share by Application (2019-2030)
Figure 64. MEALA Animal Stem Cell Therapy Revenue Share by Country (2019-2030)
Figure 65. Mexico Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
